Menu

Drugmaker RedHill Biopharma owes repayments to 340B covered entities, a finalized HRSA audit found.

HRSA Audit Finds Fourth Drugmaker Owes Refunds

October 13, 2023 Rich Daly, Editor in Chief Views

A fourth drugmaker owes repayment to 340B covered entities, according to final audits posted this week by federal officials. RedHill [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly